Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bram J Geller

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Cardiology Clinics|November 28, 2017
Evolving Strategies in Cardiac Arrest ManagementBram J Geller, Benjamin S Abella
Chemical Communications (Cambridge, England)|February 28, 2007
Oxacalixarenes and oxacyclophanes containing 1,8-naphthyridines: a new class of molecular tweezers with concave-surface functionalityJeffrey L Katz, Bram J Geller, Peter D Foster
Organic Letters|June 16, 2006
Synthesis of oxacalixarenes incorporating nitrogen heterocycles: evidence for thermodynamic controlJeffrey L Katz, Bram J Geller, Rebecca R Conry
European Heart Journal. Acute Cardiovascular Care|July 21, 2023
Sedation and shivering management after cardiac arrestBram J Geller, Carolina B Maciel, Teresa L May, et al.
The Journal of Extra-Corporeal Technology|December 15, 2023
Building an Extracorporeal Cardiopulmonary Resuscitation Program at a High-volume Extracorporeal Membrane Oxygenation CenterPeter C Michalakes, Walter F DeNino, Claire B Jara, et al.
Current Problems in Cardiology|July 18, 2024
Arterial hyperoxia and mortality in the cardiac intensive care unitJacob C Jentzer, Sean van Diepen, Carlos Alviar, et al.
Journal of Thrombosis and Thrombolysis|July 18, 2013
Autoantibodies to phosphorylcholine and cardiovascular outcomes in patients with acute coronary syndromes in the ATLAS ACS-TIMI 46 trialBram J Geller, Jessica L Mega, David A Morrow, et al.
American Heart Journal|September 21, 2015
Systemic, noncerebral, arterial embolism in 21,105 patients with atrial fibrillation randomized to edoxaban or warfarin: results from the Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction Study 48 trialBram J Geller, Robert P Giugliano, Eugene Braunwald, et al.
Circulation|October 29, 2020
Prevention of Complications in the Cardiac Intensive Care Unit: A Scientific Statement From the American Heart AssociationChristopher B Fordyce, Jason N Katz, Carlos L Alviar, et al.
Vascular Medicine (London, England)|April 28, 2020
Outcomes of catheter-directed versus systemic thrombolysis for the treatment of pulmonary embolism: A real-world analysis of national administrative claimsBram J Geller, Srinath Adusumalli, Steven C Pugliese, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Cardiology Clinics|November 28, 2017
Evolving Strategies in Cardiac Arrest ManagementBram J Geller, Benjamin S Abella
Chemical Communications (Cambridge, England)|February 28, 2007
Oxacalixarenes and oxacyclophanes containing 1,8-naphthyridines: a new class of molecular tweezers with concave-surface functionalityJeffrey L Katz, Bram J Geller, Peter D Foster
Organic Letters|June 16, 2006
Synthesis of oxacalixarenes incorporating nitrogen heterocycles: evidence for thermodynamic controlJeffrey L Katz, Bram J Geller, Rebecca R Conry
European Heart Journal. Acute Cardiovascular Care|July 21, 2023
Sedation and shivering management after cardiac arrestBram J Geller, Carolina B Maciel, Teresa L May, et al.
The Journal of Extra-Corporeal Technology|December 15, 2023
Building an Extracorporeal Cardiopulmonary Resuscitation Program at a High-volume Extracorporeal Membrane Oxygenation CenterPeter C Michalakes, Walter F DeNino, Claire B Jara, et al.
Current Problems in Cardiology|July 18, 2024
Arterial hyperoxia and mortality in the cardiac intensive care unitJacob C Jentzer, Sean van Diepen, Carlos Alviar, et al.
Journal of Thrombosis and Thrombolysis|July 18, 2013
Autoantibodies to phosphorylcholine and cardiovascular outcomes in patients with acute coronary syndromes in the ATLAS ACS-TIMI 46 trialBram J Geller, Jessica L Mega, David A Morrow, et al.
American Heart Journal|September 21, 2015
Systemic, noncerebral, arterial embolism in 21,105 patients with atrial fibrillation randomized to edoxaban or warfarin: results from the Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction Study 48 trialBram J Geller, Robert P Giugliano, Eugene Braunwald, et al.
Circulation|October 29, 2020
Prevention of Complications in the Cardiac Intensive Care Unit: A Scientific Statement From the American Heart AssociationChristopher B Fordyce, Jason N Katz, Carlos L Alviar, et al.
Vascular Medicine (London, England)|April 28, 2020
Outcomes of catheter-directed versus systemic thrombolysis for the treatment of pulmonary embolism: A real-world analysis of national administrative claimsBram J Geller, Srinath Adusumalli, Steven C Pugliese, et al.
Pageof 2